Status:

UNKNOWN

An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients

Lead Sponsor:

Lee's Pharmaceutical Limited

Conditions:

Kidney Transplant Recipients

BK Virus

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study is divided into two parts: ① Part I was a retrospective observational study. Kidney transplant recipients infected with BK virus (BKV) in the First Affiliated Hospital of Sun Yat-sen Univer...

Detailed Description

This study is divided into two parts: ① Part I was a retrospective observational study. Kidney transplant recipients infected with BK virus (BKV) in the First Affiliated Hospital of Sun Yat-sen Univer...

Eligibility Criteria

Inclusion

  • Kidney transplant recipients;
  • Postoperative maintenance therapy with glucocorticoid + tacrolimus +MPA;
  • Urinary BKV-DNA load ≥10\^7/L;
  • No gender limitation for recipients \> 18 years of age;
  • Voluntarily sign written informed consent.

Exclusion

  • Multiple organ transplantation;
  • Acute rejection occurred within 1 week before enrollment;
  • Recipients with signs of active infection;
  • Recipients with white blood cell count below 3,000 /cubic metre;
  • Women who are pregnant, breast-feeding, or unwilling to use appropriate contraceptive methods during the study period;
  • Patients with serious gastrointestinal diseases and active peptic ulcer disease;
  • Suffering from any mental illness;
  • Patients with severe heart disease and abnormal cardiac function;
  • Subjects with known allergy to the test drug;
  • Other competent physicians judged that the recipients were not suitable for inclusion.

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05293704

Start Date

May 1 2022

End Date

May 1 2024

Last Update

March 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, China